{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:36:45Z","timestamp":1775075805183,"version":"3.50.1"},"reference-count":53,"publisher":"Media Sphere Publishing House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2020]]},"DOI":"10.17116\/oftalma2020136042333","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:09:32Z","timestamp":1599134972000},"page":"333","source":"Crossref","is-referenced-by-count":2,"special_numbering":"Vyp. 2","title":["New possibilities in the treatment of Stargardt disease"],"prefix":"10.17116","volume":"136","author":[{"given":"N.V.","family":"Zhorzholadze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.L.","family":"Sheremet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Tanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.V.","family":"Strelnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2020136042333-1","unstructured":"Gudzenko SV, Khlebnikova OV, Beklemitcheva NA, Polyakov AV. DNA-diagnostics of hereditary retinal dystrophies, caused by mutations in ABCA4 gene. Meditsinskaya genetika. 2006;5(9):37-40. (In Russ.)"},{"key":"key-10.17116\/oftalma2020136042333-2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1012354"},{"key":"key-10.17116\/oftalma2020136042333-3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19936"},{"key":"key-10.17116\/oftalma2020136042333-4","unstructured":"Ostorovskij MA, Fel\u2019dman TB., Jakovleva MA, Lovjagina ER, Churkina LA, Kirpichnikov MP, Dolgih DA, Nekrasova OV, Korshun VA, Tahchidi HP, Borzenok SA, Shurigina MF, Ginter EK, Hlebnikova OV, Poljakov AV. Zritel\u2019nyj cikl, belok ABCR4 i monogennoe zabolevanie setchatki glaza \u2014 bolezn\u2019 SHtargardta (metody gennoj diagnostiki). Postgenomnye issledovanija i tehnologii: kollektivnaja monografija. M.: MAKS-Press; 2011. (In Russ.)"},{"key":"key-10.17116\/oftalma2020136042333-5","unstructured":"Sokolov AV, Sokolov VS, Fel\u2019dman TB, Ostrovskij MA. Interaction of pyridinium bis-trans-retinal with bilayer lipid membranes. Biologicheskie membrany. 2008;6:499-507. (In Russ.)"},{"key":"key-10.17116\/oftalma2020136042333-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2006.09.006"},{"key":"key-10.17116\/oftalma2020136042333-7","doi-asserted-by":"publisher","DOI":"10.2174\/138161209789824795"},{"key":"key-10.17116\/oftalma2020136042333-8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m000555200"},{"key":"key-10.17116\/oftalma2020136042333-9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707477104"},{"key":"key-10.17116\/oftalma2020136042333-10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.12.8269"},{"key":"key-10.17116\/oftalma2020136042333-11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-5635-4_8"},{"key":"key-10.17116\/oftalma2020136042333-12","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80602-9"},{"key":"key-10.17116\/oftalma2020136042333-13","doi-asserted-by":"publisher","DOI":"10.1134\/s000629790802003x"},{"key":"key-10.17116\/oftalma2020136042333-14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11688"},{"key":"key-10.17116\/oftalma2020136042333-15","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1513486"},{"key":"key-10.17116\/oftalma2020136042333-16","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3619-8"},{"key":"key-10.17116\/oftalma2020136042333-17","unstructured":"17. Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE). Accessed June 23, 2020.  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02402660?term=NCT02402660&rank=1"},{"key":"key-10.17116\/oftalma2020136042333-18","unstructured":"Scholl HP, Tsang SH, Kay CN, Connor TB, Gorin MB, Bernstein PS, Lam BL, Strecker Z, Zaremba JT, DeBartolomeo G, Washington I, Saad L. Stargardt disease ALK-001 phase 2 clinical trial: 12-month interim data. Investigative Ophthalmology and Visual Science. 2019;60(9):1336-1336"},{"key":"key-10.17116\/oftalma2020136042333-19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1506960112"},{"key":"key-10.17116\/oftalma2020136042333-20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-17121-0_47"},{"key":"key-10.17116\/oftalma2020136042333-21","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e318265801d"},{"key":"key-10.17116\/oftalma2020136042333-22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0820"},{"key":"key-10.17116\/oftalma2020136042333-23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10050"},{"key":"key-10.17116\/oftalma2020136042333-24","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2016132515-22"},{"key":"key-10.17116\/oftalma2020136042333-25","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e318217369e"},{"key":"key-10.17116\/oftalma2020136042333-26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.03.059"},{"key":"key-10.17116\/oftalma2020136042333-27","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.759"},{"key":"key-10.17116\/oftalma2020136042333-28","doi-asserted-by":"publisher","DOI":"10.1021\/ja107195u"},{"key":"key-10.17116\/oftalma2020136042333-29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.12.009"},{"key":"key-10.17116\/oftalma2020136042333-30","unstructured":"Fang Y, Tschulakow A, Tikhonovich T, Taubitz T, Illing B, Schultheiss S, Schraermeyer U, Julien-Schraermeyer S. Preclinical results of a new pharmacological therapy approach for Stargardt Disease and dry age-related macular degeneration. Investigative Ophthalmology and Visual Science. 2017; 58(8):256"},{"key":"key-10.17116\/oftalma2020136042333-31","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307213"},{"key":"key-10.17116\/oftalma2020136042333-32","unstructured":"32. Ophthotech Provides Update on Zimura Complement Programs for Treatment of Eye Diseases. Accessed June 23, 2020.  https:\/\/eyewire.news\/articles\/ophthotech-provides-update-on-zimura-complement-programs-for-treatment-of-eye-diseases\/"},{"key":"key-10.17116\/oftalma2020136042333-33","unstructured":"33. IVERIC Bio \u2018s Zimura\u00ae, a Novel Complement C5 Inhibitor, Met its Primary Endpoint and Reached Statistical Significance in a Phase 2b Randomized, Controlled Clinical Trial in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration. Accessed June 23, 2020.  https:\/\/www.businesswire.com\/news\/home\/20191028005259\/en\/IVERIC-bio%E2%80%99s-Zimura%C2%AE-Complement-C5-Inhibitor-Met"},{"key":"key-10.17116\/oftalma2020136042333-34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0737855100"},{"key":"key-10.17116\/oftalma2020136042333-35","doi-asserted-by":"publisher","DOI":"10.1097\/mco.0b013e32802b7030"},{"key":"key-10.17116\/oftalma2020136042333-36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv386"},{"key":"key-10.17116\/oftalma2020136042333-37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7522-8_11"},{"key":"key-10.17116\/oftalma2020136042333-38","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.147"},{"key":"key-10.17116\/oftalma2020136042333-39","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11871"},{"key":"key-10.17116\/oftalma2020136042333-40","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.78"},{"key":"key-10.17116\/oftalma2020136042333-41","unstructured":"Oxford BioMedica Announces Ocular Clinical Programme Update. 19\/11\/2012. Accessed June 23, 2020.  https:\/\/www.oxfordbiomedica.co.uk\/press-releases\/oxford-biomedica-announces-positive-dsmbreview-of-ongoing-retinostat-r-and-stargen-clinical-studies\/"},{"key":"key-10.17116\/oftalma2020136042333-42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m110.191866"},{"key":"key-10.17116\/oftalma2020136042333-43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620299114"},{"key":"key-10.17116\/oftalma2020136042333-44","unstructured":"Delori F. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Investigative Ophthalmology and Visual Science. 1995;36:718-729"},{"key":"key-10.17116\/oftalma2020136042333-45","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.01.007"},{"key":"key-10.17116\/oftalma2020136042333-46","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma201713344-11"},{"key":"key-10.17116\/oftalma2020136042333-47","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5391.1145"},{"key":"key-10.17116\/oftalma2020136042333-48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1151526"},{"key":"key-10.17116\/oftalma2020136042333-49","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.19-3-193"},{"key":"key-10.17116\/oftalma2020136042333-50","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.9912"},{"key":"key-10.17116\/oftalma2020136042333-51","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2019135052226"},{"key":"key-10.17116\/oftalma2020136042333-52","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-019-0081-8"},{"key":"key-10.17116\/oftalma2020136042333-53","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18681"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:12:23Z","timestamp":1599135143000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2020\/4\/10042465X2020042333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["10.17116\/oftalma2020136042333"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2020136042333","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}